Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3414828 | Microbes and Infection | 2013 | 8 Pages |
Abstract
Using a recombinant protein N46FdFc that mimics the HIV-1 gp41 N-helix trimer to immunize mice, we identified the first IgM monoclonal antibody 18D3 that specifically bound to the conserved gp41 pocket. Its F(ab′)2 fragment potently inhibited HIV-1 Env-mediated cell–cell fusion and neutralized infection by laboratory-adapted and primary HIV-1 isolates with different subtypes and tropism, including the T20-resistant variants. This F(ab′)2 fragment can be used to develop a bispecific broad neutralizing monoclonal antibody or HIV-1 inactivator as a novel immunotherapeutic for treatment and prevention of HIV-1 infection.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Lu Lu, Meili Wei, Yanxia Chen, Weiliang Xiong, Fei Yu, Zhi Qi, Shibo Jiang, Chungen Pan,